Award
National Institute of Neurological Disorders and Stroke 4U44NS121559-03
Epilepsy Seizure Detection with Innovative Tripolar EEG (tEEG)
Recipient
CREMEDICAL CORPORATION
Award Amount
$1,198,721.00
Ceiling
$1,198,721.00
Awarded
July 17, 2024
Identifier
4U44NS121559-03
Award for developing innovative EEG technology to improve epilepsy seizure detection, including device development and clinical validation with FDA clearance milestones.
Description
This project involves developing a tripolar concentric ring electrode (TCRE) sensor and a t-Interface for recording tripolar EEG (tEEG) and emulated EEG (eEEG). The goal is to improve signal fidelity, spatial resolution, and high-frequency brain activity detection to aid in epilepsy diagnosis and seizure detection. The project includes non-clinical and clinical activities to transition the device from lab to clinical use, with milestones such as FDA clearance, IRB approval, device testing, and demonstration of safety and efficacy.